about
Photodynamic endometrial ablation: morphological study.Photodynamic endometrial ablation for the treatment of dysfunctional uterine bleeding: a preliminary report.Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies.Time-dependent hexaminolaevulinate induced protoporphyrin IX distribution after topical application in patients with cervical intraepithelial neoplasia: A fluorescence microscopy study.Influence of the menstrual cycle on aminolevulinic acid induced protoporphyrin IX fluorescence in the endometrium: in vivo study.Clinical imaging fluorescence apparatus for the endoscopic photodetection of early cancers by use of Photofrin II.Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors to rodent lungs.Optical fiber-based setup for in vivo measurement of the delayed fluorescence lifetime of oxygen sensors.Reflectance imaging of the human retina at 810 nm does not suffice to optimize the parameters of hydrodynamic rebalancing laser treatment.Correlations between photoactivable porphyrins' fluorescence, erythema and the pain induced by PDT on normal skin using ALA-derivatives.Temperature and oxygen-concentration dependence of singlet oxygen production by RuPhen as induced by quasi-continuous excitation.Fluence plays a critical role on the subsequent distribution of chemotherapy and tumor growth delay in murine mesothelioma xenografts pre-treated by photodynamic therapy.Treatment of pleural malignancies by photo-induction combined to systemic chemotherapy: Proof of concept on rodent lung tumors and feasibility study on porcine chest cavities.Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease.Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment.Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot studyUptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study.In vivo measurement of tissue oxygenation by time-resolved luminescence spectroscopy: advantageous properties of dichlorotris(1, 10-phenanthroline)-ruthenium(II) hydrate.Optimization and characterization of the endogenous production of protoporphyrin IX in a yeast model.Measurement of pO2 by luminescence lifetime spectroscopy: A comparative study of the phototoxicity and sensitivity of [Ru(Phen)3 ]2+ and PdTCPP in vivo.Organometallic ruthenium(II) arene compounds with antiangiogenic activity.Human serum albumin binding and cytotoxicity studies of surfactant-cobalt(III) complex containing 1,10-phenanthroline ligand.In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy.Red and NIR light dosimetry in the human deep brain.Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study.Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid.Light-induced retinal vascular damage by Pd-porphyrin luminescent oxygen probes.Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model.Optical properties of rabbit brain in the red and near-infrared: changes observed under in vivo, postmortem, frozen, and formalin-fixated conditions.Pioneers in biomedical optics: special section honoring Professor Tayyaba Hasan.Autofluorescence detection of tumors in the human lung--spectroscopical measurements in situ, in an in vivo model and in vitro.Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy.Effect of PpIX photoproducts formation on pO2 measurement by time-resolved delayed fluorescence spectroscopy of PpIX in solution and in vivo.Photodynamic therapy and endoscopic mucosal resection as minimally invasive approaches for the treatment of early esophageal tumors: Pre-clinical and clinical experience in Lausanne.Endosomes: guardians against [Ru(Phen)3]2+ photo-action in endothelial cells during in vivo pO2 detection?Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths
P50
Q30725064-7DEA9B83-4B4B-4578-B3F3-B017FB637C5AQ31039530-A9AAC6CE-B8FA-4FF6-88FA-8AAE3680B116Q31097071-9D0838EF-061C-4845-B85B-9CB43B787C3FQ33208057-D1CCD505-4900-478D-A27D-006D0D1CC2ACQ33211705-E2FAB3C9-679E-4565-B821-67C501872864Q33318818-FEE6F2C3-7832-48E4-B98D-80F7F65B4263Q33512642-AF11CC94-AF08-4F1A-A766-1E5A2AD01E66Q33618068-D37AB6C9-7A28-45CC-A6EB-76AB6B55BBD4Q33860123-BE6CF755-F62B-42DC-B108-97A8DCC32176Q34501688-659B528F-EC7E-4577-9A02-2D19F6C445C8Q35055735-65C2FDA0-C4B5-41C5-B59E-A6DE57A4ECEDQ35372418-EF73016B-F2B2-4445-8C8F-AECE46D4E7F1Q35552850-9DEFF130-5F93-4401-8D12-BC469FE48919Q35790604-3D346AA0-111D-4AF5-AF8C-318D9092AC71Q35814444-A8287EAD-804B-4C23-A977-0714BA26B04FQ36145722-3CDBAADE-BE84-45C4-9951-B3944365010FQ36620119-EEC0FABD-B4B9-4842-BE04-5BA76945B479Q36646503-DB83196D-6168-4E37-A679-E7C6EAD3E186Q36648960-3109BF62-93A3-483E-A19A-EFA5EC473E1DQ38974373-8216DF3A-0046-4776-B13E-D6F301A1CF2EQ39078051-505F543D-4DA2-4680-99BB-013177480035Q39428442-037EC4E7-C441-493F-956F-7A25410545E2Q39550149-8790C4DF-338C-47CB-BCFD-A030A5B83AE0Q39554157-544EDAC3-0199-486E-9CA3-988A2629A906Q39732843-5A666E84-492D-452A-8F52-6A7FD95C78F5Q41193645-D2E5C36E-778D-4188-B75A-9556BF778472Q41278020-4322E001-51F3-4365-B358-894CE9E22EECQ42442315-EB5A59D3-C9E7-476E-B241-ED747B9CE1CDQ43696045-9842FA15-CB75-43FE-9A84-D11E7C596D11Q44556443-549578FA-66B3-4765-BE38-C4A531678FA8Q45280879-7D122B2C-960F-4D3A-B56B-9D6135C69865Q46965755-0C1AA3A9-A89A-4290-A860-AB7DCC179A51Q48314908-CCAFD63E-4725-4629-A8D5-9E3BCC2DA9C7Q48453532-FFEEEDD6-7D23-4AA5-8282-2DE0C1698EDCQ50453381-7F6D5BF3-BEEB-47F9-900B-76307B08B350Q50484626-FB69BF7A-8EE7-4E07-9D81-CC310BD52F7FQ51125452-DA783F0A-8565-45D2-8292-6444BAD7A093Q51536429-6BE54E06-F237-455E-8C64-97C15C5BB3ACQ52654806-D81BB8B6-FB6B-49E3-8920-C5A1F7DDF9E4Q71819924-AC907E7F-0D77-441F-870B-0BBA47DE0538
P50
description
researcher ORCID ID = 0000-0002-9082-3099
@en
wetenschapper
@nl
name
Georges Wagnieres
@ast
Georges Wagnieres
@en
Georges Wagnieres
@es
Georges Wagnieres
@nl
type
label
Georges Wagnieres
@ast
Georges Wagnieres
@en
Georges Wagnieres
@es
Georges Wagnieres
@nl
prefLabel
Georges Wagnieres
@ast
Georges Wagnieres
@en
Georges Wagnieres
@es
Georges Wagnieres
@nl
P1153
22837128400
P31
P496
0000-0002-9082-3099